Skip to content

The additive value of echocardiographic SVI to S' ratio in the diagnosis and prognosis of heart failure with preseved ejection fraction

The additive value of echocardiographic SVI to S' ratio in the diagnosis and prognosis of heart failure with preseved ejection fraction

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024903
Enrollment
Unknown
Registered
2019-08-03
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure with preseved ejection fraction

Interventions

standardized&#32
volume)&#32
and&#32
mitral&#32
ring&#32
(S&#39
Gold Standard:pulmonary capillary wedge pressure>=15mmHg was measured by right floating catheter and normal left ventricular ejection fraction (LVEF>=50%)
Index test:SVI&#32
(body&#32

Sponsors

Second Hospital Affiliated to Tianjin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: symptoms and/or signs of heart failure (typical symptoms: dyspnea, seated breathing, nocturnal parapnea, reduced exercise tolerance, fatigue, and ankle edema;Specific signs: jugular vein filling/anger tension, third heart sound running horse law, apical pulsation left displacement, etc.) and normal ejection fraction (LVEF>=50%)

Exclusion criteria

Exclusion criteria: primary cardiomyopathy (hypertrophic cardiomyopathy, invasive cardiomyopathy, restrictive cardiomyopathy, right ventricular cardiomyopathy); Constrictive pericarditis; Hyperdynamic status (anemia, pregnancy, hyperthyroidism, arteriovenous fistula); Valvular disease of the heart (stenosis, moderate to severe regurgitation); Chronic obstructive pulmonary disease, pulmonary embolism;History of myocardial infarction; Renal insufficiency (GFR<30ml/ (min*1.73m2)); Systemic diseases or other diseases that can explain the symptoms of the patient.

Design outcomes

Primary

MeasureTime frame
Cardiovascular death;Readmission rate of heart failure;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactFu Huaying

Second Hospital Affiliated to Tianjin Medical University

huayingfu@126.com+86 13820406212

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026